biostudies-literatureUnknown6(1)Blackaller GN<h4>Introduction</h4>Thyroid hormones can directly affect kidney function; elevated levels of thyroid-stimulating hormone (TSH) and chronic kidney disease (CKD) are associated with proteinuria, decreased estimated glomerular filtration rate (eGFR), and progression to end-stage renal disease. Our hypothesis is that in patients with CKD and TSH at levels considered to be in the low subclinical hypothyroidism (SCH) range, lowering TSH with levothyroxine (LVX) improves the clinical parameters of renal function.<h4>Methods</h4>This was a double-blind, randomized, pilot clinical trial in patients with proteinuric CKD (eGFR <60 ml/min per 1.73 m² and proteinuria >150 mg/d) performed at the Hospital Civil de Guadalajara, with the intention of lowering TSH (levels of 1.25-2.5 μIU/l) in pKidney international reports110-119https://www.ebi.ac.uk/biostudies/studies/S-EPMC7783574biostudies-literatureA Pilot Trial on the Effect of Levothyroxine on Proteinuria in Patients With Advanced CKD.PMC7783574Barrientos Avalos JRGarcia-Garcia GGonzalez-Torres FJMichel Gonzalez JIAguilera PMChavez-Iniguez JSRosales FRCarreon-Bautista EEBlackaller GNJose Antonio TMVillareal-Contreras MGomez Fregoso JAfalseA Pilot Trial on the Effect of Levothyroxine on Proteinuria in Patients With Advanced CKD.<h4>Introduction</h4>Thyroid hormones can directly affect kidney function; elevated levels of thyroid-stimulating hormone (TSH) and chronic kidney disease (CKD) are associated with proteinuria, decreased estimated glomerular filtration rate (eGFR), and progression to end-stage renal disease. Our hypothesis is that in patients with CKD and TSH at levels considered to be in the low subclinical hypothyroidism (SCH) range, lowering TSH with levothyroxine (LVX) improves the clinical parameters of renal function.<h4>Methods</h4>This was a double-blind, randomized, pilot clinical trial in patients with proteinuric CKD (eGFR <60 ml/min per 1.73 m² and proteinuria >150 mg/d) performed at the Hospital Civil de Guadalajara, with the intention of lowering TSH (levels of 1.25-2.5 μIU/l) in p2021-01-01T00:00:00Z2021 Jan2026-05-03T08:30:41.025Z2021-02-20T21:36:39ZS-EPMC77835743342639010.1016/j.ekir.2020.10.016